title: [The blood group incompatible living kidney transplantation].
abstract: Until recently, living kidney donations between donors and recipients of different blood groups were contraindicated. Since 2004, blood group incompatible kidney transplantations have been performed in Germany. Through the use of the anti-CD20 antibody rituximab and a highly selective immunoadsorption treatment, the recipient's antibodies against the foreign blood group are removed before the transplantation to minimize the risk of an antibody-mediated acute rejection reaction after the transplantation.
authors.affiliation: Abteilung fir Nephrologie und Allgemeinmedizin, Universitätsklinik Freiburg. johannes.donauer@uniklinik-freiburg.de
authors.forename: Johannes
authors.initials: J
authors.lastname: Donauer
mesh_terms: D000017:ABO Blood-Group System / Q000276:immunology; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D001787:Blood Group Incompatibility / Q000097:blood / Q000628:therapy; D005858:Germany; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007163:Immunosorbent Techniques; D016030:Kidney Transplantation / Q000276:immunology; D019520:Living Donors; D000069283:Rituximab
chemical_list: D000017:ABO Blood-Group System; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab